Volume 11 Supplement 1
7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Meeting abstracts
Publication of this supplement has been funded by the International congress on autoinflammatory disease (ISSAID) 2013. Abstracts are based on presentations made at the conference from ISSAID 2013.
7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID). Go to conference site.
Lausanne, Switzerland22-26 May 2013
Page 4 of 6
-
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A151
-
PW02-012 - First clinical description of an infant with DITRA
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A152 -
PW02-013 - The role of IL6 and LPS in pathogenesis of TRAPS
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A153 -
PW02-014 - Long term outcome and quality of life in TRAPS
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A154 -
PW02-015 - Eight years HPFS experience in a single UK centre
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A155 -
PW02-016 - 41 cases of TRAPS, a rare autoinflammatory disease
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A156 -
PW02-017 - New tools for the ISSAID society website
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A157 -
PW02-018 - Impact of PSTPIP1 mutaions on clinical phenotype
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A158 -
PW02-019 - Inflammatory pathways activation in TRAPS patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A159 -
PW02-020 - Colitis revealing mevalonate kinase deficiency
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A160 -
PW02-021 - SAA1 is the strongest predictor of AA in TRAPS
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A161 -
PW02-022 - Recurrent fever syndromes: multiple gene mutations
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A162 -
PW02-023 - Qualitative aspects of autoinflammatory diseases
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A163 -
PW02-024 - A case of candle syndrome treated with thalidomide
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A164 -
PW02-024-B - First report of AA amyloidosis in Blau syndrome
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A165 -
PW02-025 - Programme necrosis by CAPS-associated NLRP3
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A166 -
PW02-026 - Low frequency variants of NLRP3 in CAPS patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A167 -
PW02-027 - CAPS and cost-effectiveness analysis project
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A168 -
PW02-028 - Association of novel NLRP3 mutations with CAPS phenotype in Turkish patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A169 -
PW02-029 - Single cell fluorescent immunoassay of CINCA/NOMID
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A170 -
PW02-030 - Clinical phenotype in individuals with Q703K
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A171 -
PW02-031 - Genetic and clinical manifestations of CAPS
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A172 -
PW02-032 - CNS manifestations and NLRP3/CIAS1 gene mutations
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A173 -
PW02-033 - Cytokine profile in CSF in CAPS patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A174 -
PW02-034 - NLRP3 mosaicism detection in CAPS using NGS
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A175 -
PW02-035 - A role for thermo-TRP channels in innate immunity?
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A176 -
PW02-036 - Thermosensitive CA2+ assay innate immune cells
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A177 -
PW02-037 - The Eurofever cohort of 136 patients with CAPS
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A178 -
PW02-038 - Treatment-resistant NOMID with autoantibodies
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A179 -
PW02-039 - Long-term anakinra treatment in CAPS: a metaanalys
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A180 -
PW02-040 - Low-penetrance NLRP3 variants
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A181 -
PW02-041 - Canakinumab treatment regimens in CAPS-patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A182 -
PW02-042 - Induction of MDSC in Muckle-Wells syndrome
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A183 -
OR9-001 - Exome sequencing in monogenic Behçet-like disease
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A184 -
OR10-001 - Altered mitochondrial ROS and metabolism in TRAPS
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A185 -
OR10-002 - A novel TNFR1 transcript of TRAPS gene
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A186 -
OR10-004 - Circulating micrornas in TRAPS
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A187 -
OR10-005 - Treatment responses in TRAPS: Eurofever/ Eurotraps
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A188 -
OR10-006 - Canakinumab in patients with TRAPS
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A189 -
OR11-001 - Protein misfolding in mevalonate kinase deficiency
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A190 -
OR11-002 - Mutations in MVK cause non-syndromic RP
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A191 -
OR11-003 - The NLRP3 inflammasome is regulated by CaSR
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A192 -
OR11-004 - IL-1, IL-18 and cell death in NLRP3 driven disease
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A193 -
OR11-005 - Mast cells respond to pathogen signals with IL-1ß
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A194 -
OR11-006 - A mutation in NLRP1A causes autoinflammation
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A195 -
P03-001 - PFAPA and MEFV genes
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A196 -
P03-002 - Different phenotypes associated with Q703K variant
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A197 -
P03-003 - Sacroilitis with propionibacterium acnes
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A198 -
P03-004 - Production of proinflammatory cytokines in PFAPA
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A199 -
P03-005 - MEFV heterozygous mutations in PFAPA patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A200
Official journal of
Annual Journal Metrics
-
2022 Citation Impact
2.5 - 2-year Impact Factor
3.0 - 5-year Impact Factor
1.035 - SNIP (Source Normalized Impact per Paper)
0.732 - SJR (SCImago Journal Rank)2022 Speed
10 days submission to first editorial decision for all manuscripts (Median)
108 days submission to accept (Median)2022 Usage
901,346 downloads
750 Altmetric mentions